Skip to navigation Skip to content

Narcolepsy Program in Pharmaceutical Benefits Scheme (PBS) 012-18051127

Expand/Collapse all sectionsExpand all


This document outlines details of PBS-subsidised armodafinil and modafinil for patients with narcolepsy.

Narcolepsy and listing dates

Narcolepsy is a chronic neurological disorder of excessive daytime sleepiness.

Listing dates:

  • modafinil - 1 April 2005
  • armodafinil - 1 November 2016

Processing in OPA

Service Officers allocated the form for Initial 1 (narcolepsy without cataplexy) will need to upload the supporting documents provided in the application into the Online Pharmaceutical Benefits Scheme (PBS) Authorities System (OPA System) (Attach Supporting Document screen).

Supporting documents required for assessment and upload may include:

  • Electroencephalograph (EEG) test report
  • Multiple Sleep Latency Test (MSLT) report
  • Polysomnography test report

See Table 2 in Online Pharmaceutical Benefits Scheme (PBS) Authorities System (OPA System) for more details on processing the application in OPA.

Enquiries

Transfer enquiries about prescription arrangements to Complex Drugs Programs, and choose the option relevant to the condition treated.

The Resources page contains:

  • application forms
  • contact details
  • item and restriction codes
  • the PBS schedule
  • Services Australia website link

Online Pharmaceutical Benefits Scheme (PBS) Authorities System (OPA System)

Process telephone Authority approval application

Processing and National Demand Allocation (PaNDA)

Processing Complex Authority Required Listings

Processing Written Authority requests

Written Authority Required Drugs